NCT05461872

Brief Summary

To review the characteristic, presentation and outcome of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 18, 2022

Completed
25 days until next milestone

Study Start

First participant enrolled

August 12, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 15, 2022

Status Verified

August 1, 2022

Enrollment Period

1.4 years

First QC Date

June 23, 2022

Last Update Submit

August 12, 2022

Conditions

Keywords

Paediatricovarian cystovarian tumortorsionadolescent adnexal mass

Outcome Measures

Primary Outcomes (8)

  • To review the characteristic of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the characteristic of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the imaging findings of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the imaging findings of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the biochemical markers of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the biochemical markers of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the operative record of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the operative record of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the histopathological findings of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the histopathological findings of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the post-operative complications of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the post-operative complications of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the post-operative menstrual symptoms of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the post-operative menstrual symptoms of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

  • To review the subsequent reproductive outcome of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    To review the subsequent reproductive outcome of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

    Baseline

Study Arms (1)

girls with adnexal mass

All girls who presented with adnexal mass from 0-21 years old (inclusive). Subjects will be identified from review of clinical records. Girl aged 21 or below who attended the NTEC cluster from 1990-2021 with available medical records.

Other: No intervention

Interventions

No intervention

girls with adnexal mass

Eligibility Criteria

Age1 Day - 21 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll girls who presented with adnexal mass from 0-21 years old (inclusive)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Expecting number of record will be reviewed: 300. Participant will be identified from review of clinical records. Participants aged 21 or below who attended the NTEC cluster from 1990-2021 with available medical records. Since not all data are available in each case, expecting 300 patient records will be reviewed to have target 139 completed record. Total number of females from HK census in 2021: 0-19 years old: 521857 9-11% are malignant Sample size calculation work with a 95% confidence level; Confidence interval (margin of error) of ± 5%; Population portion of 10% Population size: 521857 Sample size=139

You may qualify if:

  • girls who presented with adnexal mass
  • aged 0-21 years old

You may not qualify if:

  • Girls older than 21 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

Related Publications (7)

  • Takayasu H, Masumoto K, Tanaka N, Aiyoshi T, Sasaki T, Ono K, Chiba F, Urita Y, Shinkai T. A clinical review of ovarian tumors in children and adolescents. Pediatr Surg Int. 2020 Jun;36(6):701-709. doi: 10.1007/s00383-020-04660-w. Epub 2020 Apr 28.

    PMID: 32346848BACKGROUND
  • Akakpo PK, Derkyi-Kwarteng L, Quayson SE, Gyasi RK, Anim JT. Ovarian Tumors in Children and Adolescents: A 10-Yr Histopathologic Review in Korle-Bu Teaching Hospital, Ghana. Int J Gynecol Pathol. 2016 Jul;35(4):333-6. doi: 10.1097/PGP.0000000000000257.

    PMID: 26630227BACKGROUND
  • Amor F, Vaccaro H, Alcazar JL, Leon M, Craig JM, Martinez J. Gynecologic imaging reporting and data system: a new proposal for classifying adnexal masses on the basis of sonographic findings. J Ultrasound Med. 2009 Mar;28(3):285-91. doi: 10.7863/jum.2009.28.3.285.

    PMID: 19244063BACKGROUND
  • Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, Bourne T, Brown DL, Coleman BG, Frates MC, Goldstein SR, Hamper UM, Horrow MM, Hernanz-Schulman M, Reinhold C, Rose SL, Whitcomb BP, Wolfman WL, Glanc P. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020 Jan;294(1):168-185. doi: 10.1148/radiol.2019191150. Epub 2019 Nov 5.

    PMID: 31687921BACKGROUND
  • Stankovic ZB, Sedlecky K, Savic D, Lukac BJ, Mazibrada I, Perovic S. Ovarian Preservation from Tumors and Torsions in Girls: Prospective Diagnostic Study. J Pediatr Adolesc Gynecol. 2017 Jun;30(3):405-412. doi: 10.1016/j.jpag.2017.01.008. Epub 2017 Jan 27.

    PMID: 28137453BACKGROUND
  • Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, Paladini D, Van Calster B, Vergote I, Van Huffel S, Valentin L. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008 Jun;31(6):681-90. doi: 10.1002/uog.5365.

    PMID: 18504770BACKGROUND
  • Aldrink JH, Gonzalez DO, Sales SP, Deans KJ, Besner GE, Hewitt GD. Using quality improvement methodology to improve ovarian salvage for benign ovarian masses. J Pediatr Surg. 2017 Oct 10:S0022-3468(17)30638-3. doi: 10.1016/j.jpedsurg.2017.10.016. Online ahead of print.

    PMID: 29106919BACKGROUND

MeSH Terms

Conditions

Ovarian CystsOvarian Neoplasms

Condition Hierarchy (Ancestors)

CystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesEndocrine Gland NeoplasmsNeoplasms by SiteGenital Neoplasms, FemaleUrogenital Neoplasms

Study Officials

  • KAREN NG, PI

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

KATHERINE LEE, Investigator

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 23, 2022

First Posted

July 18, 2022

Study Start

August 12, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

August 15, 2022

Record last verified: 2022-08

Locations